Evidence map›Paper›PMID 38847267›Full record

ReviewOncology reports2024

Unravelling the therapeutic potential of forkhead box proteins in breast cancer: An update (Review).

Sadaf Anwar, Mubashir Zafar, Malik Asif Hussain, Naveed Iqbal, Abrar Ali, Sadaf, Simran Kaur, Mohammad Zeeshan Najm, Mohd Adnan Kausar

Abstract readReview
In one paragraph

Review in Oncology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sadaf AnwarDepartment of Biochemistry, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Mubashir ZafarDepartment of Family and Community Medicine, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Malik Asif HussainDepartment of Pathology, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Naveed IqbalDepartment of Obstetrics and Gynecology, College of Medicine, University of Ha'il 2440, Saudi Arabia.
Abrar AliDepartment of Ophthalmology, College of Medicine, University of Ha'il 2440, Saudi Arabia.
SadafDepartment of Biotechnology, Jamia Millia Islamia, New Delhi 110025, India.
Simran KaurSchool of Biosciences, Apeejay Stya University, Sohna, Gurugram, Haryana 122103, India.
Mohammad Zeeshan NajmSchool of Biosciences, Apeejay Stya University, Sohna, Gurugram, Haryana 122103, India.
Mohd Adnan KausarDepartment of Biochemistry, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer, a prominent cause of mortality among women, develops from abnormal growth of breast tissue, thereby rendering it one of the most commonly detected cancers in the female population. Although numerous treatment strategies are available for breast cancer, discordance in terms of effective treatment and response still exists. Recently, the potential of signaling pathways and transcription factors has gained substantial attention in the cancer community; therefore, understanding their role will assist researchers in comprehending the onset and advancement of breast cancer. Forkhead box (FOX) proteins, which are important transcription factors, are considered crucial regulators of various cellular activities, including cell division and proliferation. The present study explored several subclasses of FOX proteins and their possible role in breast carcinogenesis, followed by the interaction between microRNA (miRNA) and FOX proteins. This interaction is implicated in promoting cell infiltration into surrounding tissues, ultimately leading to metastasis. The various roles that FOX proteins play in breast cancer development, their intricate relationships with miRNA, and their involvement in therapeutic resistance highlight the complexity of breast cancer dynamics. Therefore, recognizing the progress and challenges in current treatments is crucial because, despite advancements, persistent disparities in treatment effectiveness underscore the need for ongoing research, with future studies emphasizing the necessity for targeted strategies that account for the multifaceted aspects of breast cancer.

Indexed as

Breast NeoplasmsForkhead Transcription FactorsMicroRNAsCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansSignal TransductionForkhead Transcription FactorsMicroRNAsbreast cancerdrug resistanceforkhead box proteinsmetastasismicroRNA

Identifiers

PMID38847267
PMCPMC11177173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.